Walter Strapps

Dr. Walter R. Strapps is the Co-founder and CEO of Carver Biosciences, Inc. Prior to taking the leadership role at Carver, he was Chief Scientific Officer at Gemini Therapeutics where he led all aspects of pre-clinical research, PK and biomarkers for Gemini’s clinical trials. Before joining Gemini, Dr. Strapps was Vice President of Discovery at Intellia Therapeutics, leading programs across a range of therapeutic areas. Dr. Strapps held previous roles in RNA Therapeutics at Merck & Co., Inc in Pennsylvania and California and at Sirna Therapeutics and Sentigen Biosciences in Colorado and New York respectively. Dr. Strapps obtained his doctorate, M.A. and M.Phil. degrees from Columbia University and B.Sc. from McGill University. Dr. Strapps serves on the board of Sona Nanotech. Walter was born and raised in Nova Scotia and is a proud Bluenoser.